References
- Ribeiro M. O., Antunes E., De Nucci G., Lovisolo S. M., Zatz R. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 1992; 20: 298–303
- Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: Physiology pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109–142
- Mayhan W. G. Impairment of endothelium-dependent dilatation of the basilar artery during diabetes mellitus. Brain Res 1992; 580: 297–302
- Pieper G. M., Langenstroer G.J., Gross P. Hydroyl radicals mediate indury to endothelium-dependent relaxation in diabetic rat. Mol Cell Biochem 1993; 122: 139–145
- Under L., Kiowski W., Buhler F. R., Luscher T. F. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation 1990; 81: 1762–1767
- Epstein M., Sowers J. R. Diabetes mellitus and hypertension. Hypertension 1992; 19: 403–418
- Moncada S., Palmer R. M., Higgs E. A. Biosynthesis of nitric oxide from L-arginine: A pathway for the regulation of cell function and communication. Biochem Pharmacol 1989; 38: 1709–1715
- Moore P. K., Al-Swayeh O. A., Chong N. W.S., Evans R. A., Gibson A. L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilation in vitro. Br J Pharmacol 1990; 99: 408–412
- Ahmad S. Angiotensin receptor antagonists delay nitric oxide deficient stroke in stroke-prone rats. Eur J Pharmacol 1997; 333: 39–45
- Arnal J. F., Warin L., Michel J. B. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest 1992; 90: 647–652
- Forsting M., Reith W., Schabitz W., Heiland S., Kummer R., Hacke W., Sartor K. Decompressive craniectomy for cerebral infarction. Stroke 1995; 26: 259–264
- Okamoto K., Yamori Y., Nagaoka A. Establishment of the stroke-prone spontaneously hypertensive rat (SHR). Circ Res 1974; 34/35(suppl I)I-143–I-153
- Stier C. T., Jr, Benter. I.F., Ahmad S., Zuo H., Selig N., Roethel S., Levine S., Itskovitz H. D. Enlapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats. Hypertension 1989; 13: 115–121
- Ono H., Ono Y., Frohlich E. D. ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats. Hypertension 1996; 27: 176–183
- Powell J. S., Clozel J. P., Muller R. K., Kuhn H., Hefti F., Hosany M., Baumgartner H. R. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989; 245: 186–188
- Kontos H. A., Wei E. P., Raper A. J., Patterson J. L. Local mechanism of CO2 action on catpial arteries. Stroke 1977; 8: 226–229
- Loutzenhiser R., Matsumoto Y., Okawa W., Epstein M. H(+)-induced vasodilation of rat aorta is mediated by alterations in intracellular calcium sequestration. Cir Res 1990; 67: 426–439
- Landry D. W., Oliver J. A. The ATP-sensitive K+channel mediates hypotension in endotoxemia and hypoxic lacticacidosis in dog. J Clin Invest 1992; 89: 2071–2074
- Nelson M. T. Ca2+-activated potassium channels and ATP-sensitive potassium channels as modulators of vascular tone. Trend Cardiovasc Med 1993; 3: 54–60
- Kinoshita H., Katusic Z. S. Role of potassium channels in relaxations of isolated canine basilar arteries to acidosis. Stroke 1997; 28: 433–437
- Shigeno T., Clozel M., Sakai S., Saito A., Goto K. The effect of bosentan, a new potent endothelin receptor antagonist, on the pathogenesis of cerebral vasospasm. Neurosurgery 1995; 37: 87–91
- Ehrenreich H., Schilling L. New developments in the understanding of cerebral vasoregulation and vasospasm: the endothelin-nitric oxide network. Cleve Clin J Med 1995; 62: 105–116
- Ferri C., Pittoni V., Piccoli A., Laurenti O., Cassone MR., Bellini C., Properzi G., Valesini G., DeMattia G., Santucci A. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab 1995; 80: 829–835